StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.90+0.70 (+21.87%)

Close on Nov 17, 2026Market cap $44.27MP/E –Yield –

ImageneBio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ImageneBio's revenue for the twelve months ending Dec 31, 2025 was $800.00K, down 77.1% year over year. For fiscal 2025 it was $800.00K, down 77.1% from the year before. The highest annual figure on record is $30.99M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$800.00K-77.1%
FY2024Dec 31, 2024$3.50M-61.8%
FY2023Dec 31, 2023$9.16M-41.3%
FY2022Dec 31, 2022$15.62M-49.6%
FY2021Dec 31, 2021$30.99M+237.0%
FY2020Dec 31, 2020$9.19M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$800.00K-32.5%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$3.50M-34.1%
Q4 FY2023Dec 31, 2023$659.00K-87.9%
Q3 FY2023Sep 30, 2023$1.19M-81.5%
Q2 FY2023Jun 30, 2023$2.00M+424.6%
Q1 FY2023Mar 31, 2023$5.31M+57.0%
Q4 FY2022Dec 31, 2022$5.45M-73.0%
Q3 FY2022Sep 30, 2022$6.40M+70.9%
Q2 FY2022Jun 30, 2022$382.00K-89.2%
Q1 FY2022Mar 31, 2022$3.38M-2.6%
Q4 FY2021Dec 31, 2021$20.22M+31003.1%
Q3 FY2021Sep 30, 2021$3.75M+32.4%
Q2 FY2021Jun 30, 2021$3.55M+15.5%
Q1 FY2021Mar 31, 2021$3.47M+7.7%
Q4 FY2020Dec 31, 2020$65.00K–
Q3 FY2020Sep 30, 2020$2.83M–
Q2 FY2020Jun 30, 2020$3.07M–
Q1 FY2020Mar 31, 2020$3.23M–

More ImageneBio figures

See a number that looks wrong?